Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
One of those side effects is a type of vision loss experienced by some patients
GLP-1s (glucagon-like peptide-1) are a class of FDA-approved medications used to treat type 2 diabetes and manage weight
Our clinical team will discuss what is available and appropriate for you at your consultation
In 2014, Saxenda became the first GLP-1 analog approved for weight loss, and in 2021, semaglutide (Wegovy), became the second GLP-1 analog to receive this indication
US$ 26.17
US$ 23.54
US$ 20.79
US$ 24.24
